Future Oncology, Volume 19, Issue 8 (2023)

Browse this journal
Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 19, Issue 8 (2023)

See all volumes and issues
Vol 20, 2024 Volume 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Breaking the mold: asciminib as a standard-of-care of the therapeutic armamentarium of chronic myeloid leukemia in the upfront setting
Reyhan Yılmaz & Ahmet Emre Eşkazan
Pages: 545-547
Published online: 11 Apr 2023
First Page PreviewforBreaking the mold: asciminib as a standard-of-care of the therapeutic armamentarium of chronic myeloid leukemia in the upfront setting | Full Text | References | PDF (1.2 MB) | EPUB
  • 186 Views
  • 0 CrossRef citations
  • 0Altmetric

Plain Language Summary of Publication

Plain Language Summary of Publication
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer
Patrick M Forde, Jonathan Spicer, Shun Lu, Mariano Provencio, Tetsuya Mitsudomi, Mark M Awad, Enriqueta Felip, Stephen R Broderick, Julie R Brahmer, Scott J Swanson, Keith Kerr, Changli Wang, Tudor–Eliade Ciuleanu, Gene B Saylors, Fumihiro Tanaka, Hiroyuki Ito, Ke Neng Chen, Moishe Liberman, Everett E Vokes, Janis M Taube, Cecile Dorange, Junliang Cai, Joseph Fiore, Anthony Jarkowski, David Balli, Mark Sausen, Dimple Pandya, Christophe Y Calvet & Nicolas Girard
Pages: 549-557
Published online: 23 Feb 2023
AbstractforPlain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non–small-cell lung cancer | PDF (1.8 MB) | Supplemental
  • 9559 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Clinical Trial Protocol

Review Article
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment
Nicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, Massimo Cristofanilli, Giampaolo Bianchini, Stephen Chia, Hiroji Iwata, Wolfgang Janni, Cynthia X Ma, Erica L Mayer, Yeon Hee Park, Steven Fox, Xiaochun Liu, Sasha McClain & Francois-Clement Bidard
Pages: 559-573
Published online: 18 Apr 2023
AbstractforDesign of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
Infographic: A PDF version of this infographic is available as supplemental material.
  • 8304 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Short Communication

Brief Report
Treatment patterns, healthcare resource utilization and costs of HER2-negative gastric/gastroesophageal junction cancer
Rupali Fuldeore, Leonardo Passos Chaves, Qi Feng, Nigel Rozario, David Nimke & Stephanie Braun
Pages: 575-586
Published online: 21 Apr 2023
AbstractforTreatment patterns, healthcare resource utilization and costs of HER2-negative gastric/gastroesophageal junction cancer | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 1121 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
Preoperative assessment of high-grade endometrial cancer using a radiomic signature and clinical indicators
Tao Zheng, Jiangyang Pan, Dan Du, Xin Liang, Huiling Yi, Juan Du, Shuo Wu, Lanxiang Liu & Gaofeng Shi
Pages: 587-601
Published online: 25 Apr 2023
AbstractforPreoperative assessment of high-grade endometrial cancer using a radiomic signature and clinical indicators | Full Text | References | PDF (8.1 MB) | EPUB | Supplemental
  • 66 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Review Article
Real-world evidence in lung and hematologic oncology health technology appraisals: a review of six assessment agencies
Sharada Harricharan, Eileen Curran, Huamao Mark Lin, Laura Walton, Khushboo Gurjar, Khoi Nguyen & Anna Forsythe
Pages: 603-616
Published online: 21 Apr 2023
AbstractforReal-world evidence in lung and hematologic oncology health technology appraisals: a review of six assessment agencies | Full Text | References | PDF (1.5 MB) | EPUB
  • 160 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed et al.
Method | Published online: 23 Jul 2024
Gastric cancer in pregnancy: a review
Hongming Liu et al.
Review Article | Published online: 23 Jul 2024
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase
Ziyuan Shen et al.
Article | Published online: 23 Jul 2024
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Juanjuan Dai et al.
Method | Published online: 21 Jul 2024
View all latest articles